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The REF-1 family proteins are distinguished by the presence of two basic helix-loop 
helix domains. The REF-1 family members are considered functional homologs of the 
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HLH-25 has not been studied extensively. In preliminary studies from our laboratory, genes 
identified by microarray analysis of hlh-25 mutants were essential for embryogenesis, larval 
development, and growth. Thus, the present study was designed to further characterize HLH-25 
and to more precisely define its role during embryonic and larval development. The gene 
encoding HLH-25 is actively expressed in embryos, larvae and adults. In the absence of hlh-25, 
animals show a 54% embryonic lethality, a reduced brood size, an increased number of 
unfertilized eggs, a slower movement rate, a longer life span, and a longer dauer recovery. The 
human tumor suppressor PTEN homolog, daf-18 is one of the HLH-25 target genes.   
 
INDEX WORDS: HES; bHLH; daf-18; Dauer; Longevity; Embryogenesis 
CHARACTERIZATION OF ONE OF THE REF-1 FAMILY MEMBERS, 
HLH-25, IN C. ELEGANS 
 
 
 
 
by 
 
 
 
 
RAYMARIE GÓMEZ-VÁZQUEZ 
 
 
 
 
 
 
A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of 
Master of Science 
in the College of Arts and Sciences 
Georgia State University 
2014 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Raymarie Gómez-Vázquez 
2014  
CHARACTERIZATION OF ONE OF THE REF-1 FAMILY MEMBERS,  
HLH-25, IN C. ELEGANS 
 
 
by 
 
 
RAYMARIE GÓMEZ-VÁZQUEZ 
 
Committee Chair:  Casonya M. Johnson 
 
Committee: Walter W. Walthall 
Margo A. Brinton 
 
 
 
Electronic Version Approved: 
 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
May 2014 
iv 
 
 
DEDICATION 
Every success I have achieved in my life depends largely on the encouragement and 
guidance from my family and friends; hence this thesis is dedicated to them.  
First of all, I would like to dedicate this to the one I love, my beloved husband Alfredo 
Matos Marin. You always encourage me to strive towards my goal, and I cannot say thank you 
enough for your tremendous support and the help you have shown me. Without your 
encouragement and motivation I would not have made it this far. Thank you for all of the 
sacrifices that you have made for me. 
Next, I would like to dedicate this to my dear mother, María M. Cruz whose love for me 
knew no bounds and, who taught me the value of hard work. Thank you for your support, cheers, 
and prayers. I am grateful to have a big supportive family, and so I would like to give a special 
thank you to my siblings and their spouses: Jennifer, Pamela, Orlando, Danny, Dennis, David, 
Robert, Cesar, Carol, Cecibel, and Gema; my grandmother Barbara Vázquez, my stepfather 
Danny Cruz, my mother-in law Nylma Marin, and father-in-law Alfredo Matos. Thank you for 
your support and encouragement. 
I would like to thank God since he was a major source of strength while working on my 
thesis research.” The LORD is my strength and my shield; my heart trusts in him, and he helps 
me. My heart leaps for joy, and with my song I praise him” , Psalm 28:7 NIV.  Finally but not 
least, I would like to thank my brothers and sisters in Senda de Restauración, Inc Church for 
their support, perspective, and encouragement and specially to Pastor Ezequiel and Dr. Raquel 
Velez . 
  
v 
ACKNOWLEDGEMNT 
I take this opportunity to express my gratitude to the people who have been instrumental 
in the successful completion of this thesis.  I would like to express my special appreciation and 
thanks to my advisor and committee chair Dr. Casonya M. Johnson. Thank you for encouraging 
my research and for giving me the opportunity to work and grow as a research scientist.  I would 
also like to thank my committee members, Dr. Walter W. Walthall and Dr. Margo A. Brinton, 
for taking time from your busy schedules and serving as my committee members. Thank you for 
your guidance, comments, insights and suggestions. 
I would also like to thank the members of the Johnson and Walthall Labs for their 
constant help, support, suggestions, and ideas; Chaquettea Felton, Than Quach, Ana White, Thai 
Tran, Emma Blasingame, Sharri Ship, Richard Campbell, Shelley Hinkle.  I would like to thank 
Dr. Han Ting Chou for the design and microinjection of hlh-25::GFP.  I would also like to 
extend my gratitude to the Graduate Coordinators, LaTesha Warren and Moneka Jones for 
always being there and for making my life as a graduate student so much easier. 
  
  
vi 
TABLE OF CONTENTS 
DEDICATION.................................................................................................................. iv 
ACKNOWLEDGEMNT .................................................................................................. v 
LIST OF TABLES ........................................................................................................... ix 
LIST OF FIGURES .......................................................................................................... x 
1     INTRODUCTION...................................................................................................... 1 
1.1 Transcription Factors ......................................................................................... 1 
1.2 The Basic Helix Loop Helix (bHLH) superfamily ............................................ 2 
1.3 Hairy/Enhancer of Split (HES) .......................................................................... 4 
1.4 REF-1 family proteins ......................................................................................... 5 
1.5 Caenorhabditis elegans ....................................................................................... 9 
1.6 Objective ............................................................................................................ 10 
2 EXPERIMENTAL METHODS .............................................................................. 11 
2.1 Nematodes Strains and Maintenance .............................................................. 11 
2.2 Constructs and Transgenic Lines .................................................................... 12 
2.3 Nematode Transformation ............................................................................... 13 
2.4 Microscopy ......................................................................................................... 14 
2.5 Embryonic Lethality and Unfertilized Oocytes Assay ................................... 14 
2.6 Life Span Assay ................................................................................................. 14 
2.7 Dauer Recovery Assay ...................................................................................... 15 
vii 
2.8 Mobility Assays .................................................................................................. 15 
2.8.1 Locomotion and Thrashing Assay ................................................................ 15 
2.9 Total RNA Isolation .......................................................................................... 15 
2.10 RTqPCR ......................................................................................................... 16 
2.11 Strain Crossing .............................................................................................. 16 
2.12 Live Embryo Imaging ................................................................................... 17 
3 RESULTS .................................................................................................................. 18 
3.1 Temporal and Spatial expression profile of HLH-25 ..................................... 18 
3.1.1 HLH-25 is expressed in embryos .................................................................. 18 
3.1.2 HLH-25 is expressed in larval stages and in adults .................................... 19 
3.1.3 HLH-25 is expressed in the dauer stage ...................................................... 20 
3.2 Phenotypes of hlh-25 animals ........................................................................... 20 
3.2.1 HLH-25 affects embryogenesis .................................................................... 20 
3.2.2 hlh-25 animals have an increased unfertilized egg laying behavior .......... 21 
3.2.3 hlh-25 animals have a slower movement rate .............................................. 22 
3.2.4 HLH-25 affects organization and formation of the germline ..................... 23 
3.2.5 HLH-25 has a role in Early Embryonic Cell Division ................................ 23 
3.3 HLH-25 transcriptional network ..................................................................... 24 
3.3.1 Confirmation of HLH-25 target genes by RT-qPCR ................................... 24 
3.3.2 Confirmation of HLH-25 target genes by Transcriptional Reporters ........ 26 
viii 
3.3.3 Genetic validation that daf-18 is a target of HLH-25 .................................. 28 
3.3.4 HLH-25 animals have a longer life span ..................................................... 28 
3.3.5 HLH-25 is necessary for proper dauer exit timing ...................................... 29 
3.3.6 DAF-18 does not affect movement ............................................................... 30 
4 DISCUSSION ............................................................................................................ 52 
4.1 HLH-25 Functions During Embryogenesis..................................................... 52 
4.1.1 Is hlh-25 a maternal effect gene? ................................................................. 52 
4.2 Why is the morphology of  oocytes irregular in hlh-25 animals? Why do hlh-
25 animals have a high embryonic lethality, increased quantity of unfertilized eggs and 
reduced brood size? ................................................................................................................. 54 
4.3 HLH-25 Function in Movement ....................................................................... 55 
4.3.1 Are hlh-25 animals UNC variants? .............................................................. 55 
4.4 Stage Dependent Regulation by HLH-25 ........................................................ 56 
4.4.1 Does HLH-25 act as both, a transcriptional activator and a transcriptional 
repressor? 56 
4.5 HLH-25 links Notch signaling to the PTEN pathway. ................................... 58 
REFERENCES ................................................................................................................ 60 
APPENDICES ................................................................................................................. 79 
 
  
ix 
LIST OF TABLES 
Table 1 DNA Consensus Sequences................................................................................. 8 
Table 2 RTqPCR  Log 2 Comparison of hlh-25 with wild-type .................................. 44 
Table 3 Life Span Measurements .................................................................................. 48 
Table 4 Dauer Recovery ................................................................................................. 49 
Table 5 Location of the HLH-25 binding sites ............................................................. 57 
Table 6 Primers ............................................................................................................... 79 
Table 7 RTqPCR Probes ................................................................................................ 80 
 
  
x 
LIST OF FIGURES 
Figure 1 Domain Organization of HES and REF-1 family members. ............................... 6 
Figure 2 C. elegans Life Cycle at 25°C. ............................................................................ 9 
Figure 3 C. elegans Hermaphrodites ................................................................................ 10 
Figure 4 Transcription Reporter ....................................................................................... 12 
Figure 5 Microinjection. .................................................................................................. 13 
Figure 6 Release of embryos ............................................................................................ 17 
Figure 7  Embryonic Expression of Phlh-25::GFP. ......................................................... 31 
Figure 8 Embryonic Expression of Phlh-25::GFP. .......................................................... 32 
Figure 9 Larvae  Expression of Phlh-25::GFP.. ............................................................... 33 
Figure 10 Adult  Expression of Phlh-25::GFP. ................................................................ 34 
Figure 11 Phlh-25::GFP expression in dauer. .................................................................. 35 
Figure 12  Phlh-25::GFP  expression in the dauer head. ................................................. 36 
Figure 13  HLH-25 affects embryogenesis. ..................................................................... 37 
Figure 14 Unfertilized Egg Laying Behavior of hlh-25 compared to wild-type. ............ 38 
Figure 15 Dauer Mobility Assay ...................................................................................... 39 
Figure 16  L4 Locomotion and Thrashing ....................................................................... 40 
Figure 17 hlh-25 depletion causes irregular shape of oocytes ......................................... 41 
Figure 18 Early Embryonic Cell Division Time-lapse video. ......................................... 42 
Figure 19 HLH-25 targets expression during L4 stage. ................................................... 43 
Figure 20 akt-2::GFP expression. .................................................................................... 45 
Figure 21 daf-18 expression changes ............................................................................... 46 
Figure 22 daf-18 head expression changes ...................................................................... 47 
xi 
Figure 23 Life span curve of wild-type versus hlh-25. .................................................... 48 
Figure 24 Dauer Recovery. .............................................................................................. 49 
Figure 25 Locomotion Assay ........................................................................................... 50 
Figure 26 Characteristics of Dauer Recovery .................................................................. 51 
Figure 27 Role comparisons between humans and C. elegans. ....................................... 59 
 
1 
1     INTRODUCTION  
1.1 Transcription Factors 
Transcription factors are a diverse family of proteins that bind to the promoter region, a 
specific DNA section upstream of a gene, in order to regulate its expression. Transcription 
factors can also bind to multi-subunit protein complexes to manipulate transcription either 
negatively or positively [2-7], and they determine how cells function by determining the time 
and place of their gene expression.  
Transcription factors that control homeotic genes (i.e. genes that control the pattern of 
body formation) usually are vital for the normal development of the organism.  In Drosophila, 
the transcription factor Bicoid, for instance, is necessary for the embryonic development of the 
anterior half of the embryo.  Embryos with a mutation in Bicoid grow into larva with posterior 
structures at both ends and with two spiracles, instead of one, at the posterior end [8, 9].  Another 
function of transcription factors is to determine whether a gene functions or not at a given time.  
For example, HES mutations in the developing mouse embryo cause neural progenitor cells to 
prematurely differentiate causing neural defects [10] and sometimes small and deformed brain 
structures [11]. 
Transcription factors are often grouped into families based on their sequence 
similarity and their structure.  Examples of different transcription factor families include winged 
helix, zinc fingers, homeodomain proteins, zinc-finger proteins, and basic helix loop helix 
proteins.  These different families also typically have characteristic functions.  For instance, in 
humans, the transcription factor T18 is part of the zinc-finger family.  T18 acts as a breast cancer 
tumor suppressor [12]. In plants, many transcription factors from the family of basic 
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region/leucine zipper motif (bZIP) proteins, like the bZIP protein lotus, regulate processes 
including photomorphogenesis, leaf and seed development [13, 14].  
 
1.2 The Basic Helix Loop Helix (bHLH) superfamily 
Members of the basic helix-loop-helix (bHLH) transcription factor family have two 
highly conserved domains, the basic domain and the helix-loop-helix domain.  The basic domain 
is located at the N-terminus; this domain binds to specific sequences of DNA upstream of the 
promoter region [15].  The second domain contains an HLH domain located at the C-terminus 
formed by two amphipathic helices connected by a loop region consisting of amino acids [16].  
The HLH domain interacts with other proteins.  These domains are approximately 60 amino 
acids long [15].  The HLH domain binds to other proteins to form homodimeric and 
heterodimeric complexes [17].  For example, bHLH proteins LYL1 form a heterodimeric 
complex with TCF3 in hematolymphoid cells to regulate blood vessel maturation and 
hematopoiesis [18].  bHLH transcription factors also have the ability to differentially regulate 
transcription based dimerization.  For instance, in the fungal plant Fusarium oxysporum, the 
bHLH protein FoSTUA differentially regulates the development of two kinds of asexual pores, 
macroconidia and microconidia.   FoStuA acts as a positive regulator for macroconidia and as a 
negative regulator for chlamydospores during development [19]. 
Different attempts have been made to subcategorize bHLH proteins.   Atchley and Fitch 
[20], subdivided the bHLH proteins into four groups based on their binding to DNA at the 
hexanucleotide E-box, the amino acid patterns in other components of the motif, and the 
presence/absence of a leucine zipper.  Group A proteins bind to the E-box (CAGCTG) usually to 
activate  transcription.  They have a distinctive pattern of amino acids at sites 5, 8, and 13.  This 
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group has only small aliphatic residues.  An example of a group A protein in mammals is the 
MyoD protein family.  Group B proteins bind to the G-box (CACGTG).   This group has 
arginine at site 13, a basic amino acid at site 5, and an E-box configuration at sites 5–8-13. 
Protein families with a LZ motif are included in group B. Sequences with an LZ have a very high 
frequency of N residues (93%).  An example of a group B protein in Drosophila is the Hairy and 
Enhancer of split bHLH.  Group C has the PAS domain, which is a protein-protein interaction 
region. Proteins with a PAS domain usually function as signal sensors [21].  For instance, human 
PAS proteins include hypoxia-inducible factors and voltage-sensitive ion channel proteins [22].  
Group D proteins lack the DNA binding basic region, and thus, are unable to bind DNA, but they 
can form heterodimers with other bHLH proteins usually as negative regulators.  An example of 
group D in mammals is the ID protein family [23, 24]. 
The superfamily bHLH is found in many organisms including yeast, mice, worms, and 
humans.  bHLH transcription factors are involved in the regulation of many developmental 
processes including, cardiovascular development [25], mouse brain development [26, 27] , 
neurogenesis [28], cell cycle regulation, and embryogenesis [10, 29]. They typically act in 
cascades, one after the other, to cause increasing degrees of specialization.  For example, the 
regulation of the cell elongation (i.e. cell specialization) in Arabidopsis depends on a chain of 
antagonistic switches comprised of transcription factors, PREs, IBH1, and HBI1 [30]. 
Transcriptional regulators are required for the development of differentiated neurons. 
Many proteins are involved in neuron differentiation and HLH proteins regulate parts of this 
process. In mammals, different bHLH proteins work in a cascade to control different steps 
behind neurogenesis.  In mice, two bHLH transcription factors, Ascl1 and Hand2, are necessary 
at every step of the cascade for proper parasympathetic and sympathetic neuron development, 
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respectively [31].  Ascl1 has also been implicated in the differentiation of the P19 EC cells into 
neuronal cells, and reduction of Ascl1 causes delayed neurogenesis of the P19 EC cells [32].  
Hand 2 impacts development of the enteric nervous system (ENS).  Mutations in Hand2 affect 
both neural precursor and neuron numbers, such as complete loss of neuronal nitric oxide 
synthase (NOS) and vasoactive intestinal peptide (VIP) neurons [33]. 
 
1.3 Hairy/Enhancer of Split (HES)  
The Hairy/Enhancer of Split (HES) proteins form a sub-family within the bHLH 
superfamily.  The founding members of the HES family were first described in Drosophila 
where it was demonstrated that HES proteins are direct targets of Notch signaling [34-36]. Notch 
signaling is a conserved cell to cell communication necessary for proper development in many 
organisms.  Notch signaling has been implicated in the development of embryogenesis, the 
nervous system, the cardiovascular system, and the endocrine system [11, 34, 37, 38].   In 
humans, for instance, a mutation in NOTCH1 causes T-cell acute lymphoblastic leukemia [39].  
Proteins of the HES family have three structural domains: bHLH, Orange, and WRPW.  
The bHLH domain contains a highly conserved proline residue that is typically absent in other 
members of the bHLH family.  The Orange domain consists of two amphipathic helices and 
regulates the selection of bHLH heterodimer partners [11, 35].  For example, the Orange domain 
in Xenopus is required for heterodimerization of XHRT1 with Xhairy2b [40].  The WRPW 
domain is found at the C-terminal end of the protein and is required for repression of 
transcription.  This domain consists of four amino acids Trp-Arg-Pro-Trp that mediates 
degradation of its own protein.  For instance, WRPW recruits Groucho to actively repress 
transcription [41, 42].  
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Even though HES proteins are critical for normal function and play central roles in 
embryogenesis by maintaining progenitor cells in an undifferentiated state [11], little is known 
about how they work.  HES mutations have been associated with lung and breast cancer in 
mammals [43, 44]  and oocyte death [29]. 
1.4  REF-1 family proteins  
The members of the REF-1 family in C. elegans, like the HES family, are also a direct 
target of the Notch signaling [45] , but they also act in Notch-independent functions [46].  Both 
families share a sequence similarity at the bHLH domain[2], and they regulate a variety of target 
genes that influence embryo development.  Therefore, the REF-1 family members are considered 
functional homologs of the HES family. 
Unlike other bHLH members, the REF-1 family proteins are distinguished by the 
presence of two basic helix-loop helix domains instead of one [2], and unlike the HES proteins, 
REF-1 proteins do not have a conserved Orange domain [47].   The six members of the REF-1 
family are REF-1(HLH-24), HLH-25, HLH-26, HLH-27, HLH-28 and HLH-29.   The REF-1 
family also lacks the WRPW domain, but at the C-terminal of each member has a slightly 
different pentapeptide repeat sequence:  REF-1 has FRPWE; HLH-25 has LDIIN; HLH-26 has 
IDIVG; HLH-27 has VDISN; and HLH-28 and HLH-29 have IDIIG (Figure 1).   These 
pentapeptide repeat sequences have similar net charges to those of the WRPW sequences, and 
the sequences in REF-1 has been shown to interact with the C. elegans Groucho homolog [45]. 
Alignment of bHLH domains from Drosophila HES-6, the C. elegans REF-1 family and 
the C. briggsae showed that the first bHLH domain in the REF-1 family proteins is more closely 
related to each other than to the second bHLH domain, and the first bHLH domain is also 
significantly more similarto the bHLH domain in the Hairy/E(spl)/LIN-22 [2]. Therefore, we 
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postulated that the second bHLH domain in the REF-1 family could functionally replace the 
Orange domain and may act to provide stability during protein-protein interactions.  
 
 
 
 
 
 
 
 
 
 
REF-1 was the first member to be studied. It has been shown that REF-1 regulates HOX 
genes, genes that control the body plan of the embryo; thus making it an important transcription 
factors needed for development during embryogenesis [48].   Mutations to ref-1 affect cell fate 
decisions in different body regions along the C. elegans AP body axis, giving rise to aberrant 
physical phenotypes such as irregular head shapes and multivulva [48]. REF-1 also affects the V 
ray lineage in C. elegans males resulting in a partial transformation of the ray identity from V6 to 
V5 [48, 49]. 
The hlh-28 gene is nearly identical to hlh-29 and their gene products are identical [50].  
Therefore they are usually studied together.   They are expressed in all cells of the early MS and 
Figure 1 Domain Organization of HES and REF-1 family members. 
This figure was adapted from Dawson at el.1995 and Neves et al. 2005. Unlike HES, the REF-1 family 
lacks the Orange domain present in HES. It is postulated that the second basic helix-loop-helix domain 
can functionally substitute for the orange domain.   
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E lineages.  Both of these members are also involved in embryonic development and 
reproduction.  RNAi against hlh-29/hlh-28 affects the embryonic viability, adult egg-laying and 
organismal homeostasis [51].  Also, HLH-29 regulates the ability of oocytes to enter and exit the 
spermatheca, within the IP3 signaling pathway [52]  
 Even though HLH-26 and HLH-27 are known to activate in response to Notch signaling 
during embryogenesis [2], they have not yet been studied extensively. However, hlh-27 and hlh-
25 are almost identical and may work redundantly in the mesoderm and endoderm networks 
in C. elegans [46, 53].  
 HLH-25 is expressed during embryonic development in response to Notch signaling [45], 
in Abp granddaughters (beginning after eight-cell stage) and in four of the EMS granddaughters 
(MSaa, MSap, MSpa,Mspp) [45].  HLH-27 is also expressed in the early MS lineage [46, 53].   
hlh-25 is one of the MED-1 target genes which participates in specifying the mesendoderm [54].  
It has been shown that overexpression of hlh-25 restores muscle differentiation in development 
in a small proportion of embryos with skn-1 and pal-1 mutations [46, 53].   Since the cascade 
controlling muscle development incudes members of the bHLH family, MyoD, myogenin, Myf5, 
and MRF4, it is believed that HLH-25 may be involved in muscle development [46, 53]. 
Using enriched GO annotations, previous studies have shown that HLH-25 DNA binding 
specificities are associated with candidate target genes required for cytoskeleton, reproduction, 
cuticle/molting, secretion, cell division, locomotion, signaling, development, and metabolism 
[55].   In preliminary studies from our laboratory, genes identified by gene expression microarray 
analysis of hlh-25 mutants were grouped under regulation of growth, embryonic development 
ending in birth or egg hatching, nematode larval development, positive regulation of growth, 
post-embryonic development, and body morphogenesis.  
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Grove et al  [56] also used protein binding microarray (PBMs) assays to identify the DNA 
binding sequence preferences of the bHLH dimers.  They found that HLH-25 and the other REF-
1 family proteins can bind to DNA as homodimers, and that HLH-25 recognizes five different 
consensus sequences.  Interestingly, the REF-1 family member HLH-29 shared two of the five 
HLH-25 recognition sequences (table 1) [55].  
 
Table 1 DNA Consensus Sequences 
Protein CACGCG CATGCG CATACG CACACG CACGCT 
HLH-25 X X X X X 
HLH-27 X X X   
HLH-29 X X    
 
We compared the target genes identified by the gene expression microarray studies from 
our lab with those identified by PBM.  A number of targets were on both lists.  One target gene 
found on both lists was daf-18, the C. elegans ortholog of PTEN. In humans, PTEN is a tumor 
suppressor in human cancers [26].  Mutations to PTEN have resulted in the development of 
glioblastoma, colon cancer, breast cancer, and prostate cancer [57-60].  PTEN is a phosphatase 
protein involved in the regulation of the cell cycle and prevents cells from growing too rapidly 
by preventing phosphorylation of the Akt/PKB signaling pathway which is responsible for cell 
growth regulation [61-63].  In C. elegans, DAF-18, like PTEN, is a phosphatase protein involved 
in cell regulation.  DAF-18 also prevents phosphorylation of the AKT-1/AKT-2 complex in the 
insulin pathway [64] which plays a role in, development, metabolism, and longevity [65-68]. 
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1.5  Caenorhabditis elegans 
Caenorhabditis elegans (C. elegans) are transparent free-living, non-parasitic 
microscopic nematodes measuring about 1 mm in length as adults.  These round worms live in 
soil environments and feed on bacteria [69-72].   In 
laboratories, C. elegans grow in Petri-dish plates and 
feed on E. coli.  There are two sexes, a self-fertilizing 
hermaphrodite and male.  C. elegans have a short life 
span of roughly one month.  
The C. elegans life cycle is divided into the 
following stages: embryos, four larvae stages: L1, L2, 
L3, L4, and adults (Figure 2).   When these animals 
encounter a hostile environment such as high 
temperatures, little or no food, or crowdedness, they 
can go to an alternate stage called the dauer stage.  During the dauer stage, C. elegans do not age, 
eat or reproduce and their locomotion is reduced.  Surprisingly, worms that encounter this stage 
can live up to four months, four times longer than non-dauer animals.  Morphologically they are 
long, thin, and covered in a thick cuticle.  When dauer-stage animals find a suitable environment 
they resume their normal life cycle and molt directly to an L4 within a few hours [73].  
C. elegans hermaphrodites have a “U” shape gonad. The gonad consists of two ovaries, 
oviducts, spermatheca, and one uterus.  There is a distal end (DTC) of the germline on each side 
of the gonad where the somatic cells are situated (Figure 3).   As these cells move through the 
gonad they go through a series of phases.  Once they reach the loop (bend of the gonad) they are 
surrounded by plasma membrane in preparation for compartmentalization to form oocytes.  Once 
Figure 2 C. elegans Life Cycle at 25°C. 
<http://avery.rutgers.edu/WSSP/StudentS
cholars/project/introduction/worms.html> 
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fertilized, the oocytes undergo meiosis and are pushed to in the uterus, and the eggs are laid after 
approximately thirty divisions.  The fertilized 
egg forms an eggshell that protects it from the 
external environment [69, 72]. If plenty of 
food is present, hermaphrodites who run out 
of sperms may lay an average of 31 
unfertilized eggs per worm [74].  
 
 
1.6 Objective  
Since previous studies suggest that HLH-25 may be critical for embryonic and larval 
development, my objective is to further characterize HLH-25 and to precisely define its role 
during embryonic and larval development.  In order to achieve this objective, the following aims 
were developed: to determine the temporal and spatial expression profile of HLH-25, to identify 
phenotypes of hlh-25 mutants, to define the hlh-25 transcriptional network, and to determine if 
HLH-25 is required for embryonic cell division.  The key challenge in this genetic research is to 
understand how the HLH-25 transcription factor affects the performances of its target genes by 
examining phenotypes caused by hlh-25 mutations.  
  
Figure 3 C. elegans Hermaphrodites 
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2     EXPERIMENTAL METHODS 
 
2.1 Nematodes Strains and Maintenance 
The wild-type strain used in this work was Bristol N2. VC1220 [hlh-25 (ok1710) II.] and 
RB712 (daf-18(ok480) IV.), was received from the Caenorhabditis Genetics Center (CGC).  The 
daf-18 transgenic reporter strain used was FS84 (daf-2(e1370) ; daf-18(mg198); fsEx84(daf-18 
promoter::daf-18 cDNA::unc-54 3’UTR 20ng/ul + daf-18 promoter::GFP::unc-54 3’UTR 
20ng/ul (in pPD95.75) + pRF4 100ng/ul) kindly provided by Dr. Florence Solari  from Claude 
Bernard University Lyon from the European Molecular Biology Laboratory. IC748, quIS18 
[daf-18 genomic(+)] was provided by Dr. Ian D. Chin-Sang from Queen’s University, Kingston, 
ON Canada. GR1673 (akt-2::GFP; pRF4 (rol-6)) was provided by Dr. Gary Ruvkun from 
Harvard Medical School. 
The hlh-25 transgenic reporter strain used was CMJ3001 (Phlh-25::GFP(A); pRF4 (rol-
6).   Other strains used were CMJ4001 (daf-18 promoter::daf-18 cDNA::unc-54 3’UTR 20ng/ul 
+ daf-18 promoter::GFP::unc-54 3’UTR 20ng/ul (in pPD95.75) + pRF4 100ng/ul; hlh-25 
(ok1710) II.),hlh-25(VC1220); CMJ4004 (Phlh-25::GFP); Pmyo-2::mCherry::unc-54utr), and 
CMJ4003(α-tubulin::GFP; hlh-25 (ok1710) II.) 
Animals were maintained on nematode growth medium (NGM) with OP50 as a food 
source, previously described  [75].   For synchronization, embryos were collected by treatment 
with sodium hypochlorite, as previously described, [76, 77], with the following exceptions.   
Only 500µL of 5M KOH and 1mL of household bleach were added and the worms were shaken 
vigorously for no more than six minutes. 
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2.2 Constructs and Transgenic Lines 
To generate Phlh-25::GFP, 1570 bp upstream of the first ATG of hlh-25 in the coding 
sequence was amplified by PCR (see appendix A for primers) using Phusion
®
 High-Fidelity PCR 
Master Mix.  For the HLH-25 target genes daf-18, vha-1, akt-2, pqn-95, ima-1, imp-2, ntl-4, 
thoc-2, and ran-1, 2,000 bp upstream of the first ATG in the coding sequence was amplified 
using Phusion
®
 High-Fidelity PCR Master Mix.   All PCR was done using the DNA Engine 
Dyand Peltier Thermal Cycler and the products purified using the Qiagen QIAquick PCR 
Purification Kit.  The transgenes were cloned using standard techniques (Figure 4) [78, 79].    
 
 
 
 
 
 
 
 
 
 
Figure 4 Transcription Reporter 
Schematic image of a transgenic DNA construct were the (GFP) gene is under the control 
of the selected genes promoter producing a green fluorescent protein when translated into 
the region were the gene is expressed. Plasmid 1490: pPD95.67 (Fire Vector) 
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2.3 Nematode Transformation 
Microinjection has been previously described [80, 81] .  The Phlh-25::GFP DNA 
construct was microinjected as  a“simple” array and was co-injected with rol-6(su1006) as a 
marker which induces a dominant "roller" phenotype [82] in a 1:1 ratio.  The HLH-25 target in a 
DNA constructs were microinjected directly into the syncytial gonad as “complex” arrays in low 
copy number to prevent transgene silencing [81, 83].   The DNA solution consisted of the 
following components: 100 ng/µL of genomic DNA cut with PvuII, 1ng/µL of linearized 
construct, and 1ng/µL of marker rol-6(su1006).  A PCR product of genomic DNA from 1541bp 
upstream to 770 bp downstream of the hlh-25 coding sequence was co-injected with Pmyo-
2::mCherry. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Microinjection. 
 A) Site for microinjection of the DNA in the cytoplasm of the syncytial gonad. B) 
Sample needle used for microinjection. 
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2.4 Microscopy  
The transgenic worms were exposed to ultra-violet (UV) to analyze their expression and 
position by comparing GFP (green fluorescent protein) and DIC (differential interference 
contrast) images.  Animals were anesthetized with 0.2% levamisole [84], mounted on 2.0% 
agarose pads and imaged using a Nikon Eclipse 90i microscope equipped with a Nikon Coolsnap 
CCD camera.  
2.5 Embryonic Lethality and Unfertilized Oocytes Assay 
Twenty virgin L4 stage animals of each strain were singled out and placed on fresh plates 
every 24 hours.   Embryonic lethality was determined by counting the number of non-hatched 
embryos divided by the total progeny (non-hatched and hatched) and subtracting the number  
from 100% to obtain the lethality percentage.  Embryos that did not hatch after 24 hours were 
scored as dead.   The p-value of lethality was calculated using two-way ANOVA.   The 
unfertilized oocytes average was determined by moving another twenty L4 to a new plate daily 
and counting the unfertilized eggs until death or nineteen days after egg lying was reached, 
whichever ocurred first.   The percentage and p-value was calculated using the Graphpad 
Software Package. 
 
2.6 Life Span Assay 
Assays were conducted at 20°C.   During the egg laying period, these worms were 
transferred every two days to a new fresh NGM plates.   The numbers of surviving, dead and 
missing worms were counted each day.   Animals were scored as dead when they no longer 
responded to the touch of the platinum wire or were censored if missing [85, 86]. The Graphpad 
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Software Package was used for statistical analysis and to calculate p-value, means and 
percentiles.  
  
2.7 Dauer Recovery Assay 
In order to promote dauer formation more than 200 embryos were placed on each plate 
containing very little food (10µL OP50) at 27° C for a minimum of 96 hours.  Three day old 
dauers were singled out to a plate with plenty of food (OP50, 75 uL) and moved to 20° C.  Dauer 
recovery was examined by monitoring five characteristics: fat accumulation, pharyngeal 
pumping, visibility of crescent in vulvae, visibility of embryos, and visibility of eggs laid (Figure 
26) [70, 87].  
 
2.8 Mobility Assays 
2.8.1 Locomotion and Thrashing Assay 
Dauer and L4s were used to examine movement.  The locomotion rate on solid media was 
quantitated by counting body bends for one minute in a plate with no food [88].  The thrashing 
rate was obtained by counting each lateral movement made by the worms when swimming in M9 
buffer over a period of one minute [89]. 
 
2.9 Total RNA Isolation 
Embryos, L4, and dauer animals were frozen at −80°C for a minimum of twenty- four 
hours.   Each pellet was resuspended in 100 µL of freshly made lysis buffer containing 0.5% 
SDS, 5% 2-mercaptoethanol, 10 mM EDTA, 10 mM TrisHCl (pH 7.5), and 10 µL of  Proteinase 
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K [(Thermo E0Ø491) (19.2mg/mL)].  The samples were incubated at 55°C shaking at 900 rpm 
for 1 hour.   RNA was extracted using a Quiagen RNeasy Plus Kit and with following the 
protocol from the RNeasy Microhandbook for animal tissue. 
  
2.10 RTqPCR 
 cDNA was synthesized using the high capacity cDNA Reverse Transcription Kit 
(Applied Biosciences catalog #43674966), and following the instructions from the manufacturer. 
cDNA synthesis reactions were performed in 20 µL reaction volumes containing 0.5 µg of total 
RNA.  Reverse transcriptase  PCR assays were performed with Taqman Gene Expression Assays 
(Applied Biosystems) for detection of amplicon, specific for each target gene, using relative 
quantitation against the endogenous control gene pmp-3  [90].  For primer sequences see 
appendix B. 
 
2.11 Strain Crossing  
Fifty hlh-25 young adult hermaphrodites were heat shocked at 35° C for 3 hours and 
singled out in plates to screen for males [91].  Transgenic strains akt-2::GFP, daf-18::GFP, and  
α-tubuline were crossed with hlh-25 animals.  Each plate contained six males and one adult 
hermaphrodite.   To select progeny with the transgene and homozygous deletion of hlh-25, PCR 
was used to amplify the hlh-25 gene using internal primers: Left 5’ 
ACCAAACCGGAGTTCTCAAA 3’; Right 5’ AGAATGGGACATCCCACAAA 3’.   Deletion 
was confirmed by agarose gel electrophoresis. The internal wild-type amplicon is 2,113 bp and 
the deletion size is 1,550 bp. 
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2.12 Live Embryo Imaging 
Gravid adult worms were placed in a drop of M9 
buffer over a glass slide. An incision was made with a 
scalpel (or razor blade) at the vulva to release the eggs, 
(Figure 6).  Vaseline® Petroleum Jelly was applied on the 
edges of a cover slip that was then placed over the glass 
slide containing the embryos to lock moisture in.  Less than 
ten eggs were placed per slide to prevent hypoxia.  A time-lapse recording of epifluorescence 
pictures at time intervals of three minutes was taken to track the first divisions of the embryo 
with 40X or 60X objective [92]. 
 
 
  
Figure 6 Release of embryos 
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3   RESULTS 
 
3.1 Temporal and Spatial expression profile of HLH-25 
Even though it was previously shown that HLH-25 is expressed in response to Notch 
signaling during embryogenesis, its full expression profile was unknown.  As a first step to 
understanding HLH-25 and to determine the full expression of hlh-25 in live animals, we 
generated a transcriptional reporter.  This reporter consisted of the gene encoding the green 
fluorescent protein (GFP) under the control of the hlh-25 promoter. Using DIC imaging and 
epifluorescent microscopy, I observed the transcriptional reporter expression in embryos, larvae, 
including dauer larvae, and adult animals.  According to our microarray analysis, HLH-25 
regulates many important genes needed for development. Thus, I expected to observe expression 
not only in embryos, but also in the larvae stages.  
 
3.1.1 HLH-25 is expressed in embryos 
I examined eggs in utero, immediately after fertilization, or after manual extraction from 
adult hermaphrodites.   I first detected expression of Phlh-25::GFP after the ten-cell stage (Figure 
7).  This result is consistent with previous reported expression after the first embryonic Notch 
signaling event in C. elegans [45].  As the cells continued to divide mitotically, the expression 
expanded to all cells on the outer surface of the embryo.  During normal gastrulation, which 
initiates at the  26-cell stage, wild-type animals progress from the bean stage to the tadpole stage, 
and  precursor cells of the gut, germline, pharynx and body wall muscles and mesoderm migrate 
from the outer surface towards the interior of the embryo through the entry zone. I found that 
hlh-25 expression correlated with migrating cells.   Expression of Phlh-25::GFP during the bean 
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stage was located only on the outer surface of the embryo (figure 7 -8 ); however, during the 
comma stage the expression expanded. When the embryos reached the tadpole stage, I observed 
expression in the entry zone along the ventral side, in part of the anterior where the future buccal 
opening, or mouth, will form, and in the posterior region of the animal, where the future tail will 
form. Interestingly, I detected no embryonic expression immediately prior to hatching, a result 
which suggests that hlh-25 is actively silenced at some stage during embryogenesis.   
 
 
3.1.2 HLH-25 is expressed in larval stages and in adults 
After hatching, if food is available, C. elegans go through four larval stages before 
reaching adulthood.  During the first larval stage, L1, somatic gonad precursors start dividing.  
At the end of L1 stage, five of the eight types of motor neurons are made, one of which is the 
ventral nerve cord (VNC). The second larval stage is L2.  During this stage, the somatic gonad 
precursors continue dividing and give rise to the distal tip cells that are required for gonad 
elongation.  At the third larval stage, L3, the arms of the somatic gonad elongate, the 
spermathecae are formed, and sperm production begins.  In the fourth and final larval stage, L4, 
sperm production stops and meiosis in the germline begins.  Animals enter adulthood after 
exiting the L4 stage.   During adulthood, the reproductive system is complete; oocytes are made 
and reproduction commences.  I examined synchronized cultures of C. elegans hermaphrodites 
through all of the larval stages, and in adults, to characterize hlh-25 expression.  I did not detect 
expression from the Phlh-25::GFP reporter in L1 stage animals.  However, during the L2, L3, 
and L4 stages, I observed expression in unidentified head and tail neurons, and in head and body-
wall muscles (figure 9).   I also detected expression in the midbody mechanosensory PDE 
neuron.  In adults, I continued to detect expression in the head and tail neurons, but not in the 
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head or body-wall muscles (figure 10).  I also detected weak expression in the ventral nerve cord 
of some adults.  
 
3.1.3 HLH-25 is expressed in the dauer stage 
The dauer stage is an alternative stage that promotes survival when C. elegans encounter 
a hostile environment.  During this stage, animals grow a thicker cuticle that seals the buccal 
cavity, slows metabolism and inhibits reproduction.  To complete the expression profile of HLH-
25, I also examined Phlh-25::GFP expression during the dauer stage.  I detected strong Phlh-
25::GFP expression in the head neurons and VNC of every dauer animal, and occasionally, in 
the  synaptic branches between VNC and the dorsal nerve cord (Figure 11-12).   Because the 
transgene expression was mosaic and highly variable, I was unable to identify which cell bodies 
of the VNC were expressing the reporter.   
 
3.2 Phenotypes of hlh-25 animals 
To further characterize HLH-25, I sought to identify phenotypes of hlh-25 animals. 
Because hlh-25 is expressed in embryos, neurons and muscles, I believe these results are 
indicative of a possible role for HLH-25 in directing embryogenesis and body movement. Thus, I 
examined C. elegans embryonic lethality, quantity of eggs laid, and movement. 
 
3.2.1 HLH-25 affects embryogenesis 
Embryos take approximately ten hours to develop following fertilization, going through a 
series of division and folding before hatching.  hlh-25 is expressed in the embryos in response to 
Notch signaling, and expression continues throughout embryogenesis but ceases just before 
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hatching.  As a measure of the requirement for HLH-25 during embryogenesis, I examined 
embryonic viability in mutant and wild-type animals.   
Homozygous deletion of hlh-25 gave rise to embryonic lethality.  I observed 54% 
lethality in hlh-25 mutant embryos versus 14% embryo lethality in wild types embryos (Figure 
13a), representing a 3.79 fold increase (P-value = 6.32E-14).  These results correlate with a 
previous genome-wide RNAi study which showed a 40% embryonic lethality for animals 
subjected to hlh-25 RNAi.   Deletion of hlh-25 also resulted in a reduced quantity of eggs laid. 
hlh-25 animals laid a total average of 208 eggs, while wild-type animals laid an average of  249 
(P-value = 0.0565) (Figure 13b).  
 
3.2.2 hlh-25 animals have an increased unfertilized egg laying behavior 
Wild-type C. elegans hermaphrodites produce approximately 300 sperm between L3 and 
L4 stages.   As the animals progress through L4, they cease sperm production and switch to 
producing oocytes at late L4/early adulthood.  As adults, fertilization is initiated when mature 
oocytes are fertilized by sperm that reside in the spermatheca.  Normally at 20°C, the onset of 
fertilization and egg production begins at approximately 65 hours after hatching (~ 3days) and 
continues until approximately 128 hours after hatching (~5.5 days) [93, 94].   Since oocyte 
production is not the limiting factor, wild-type hermaphrodites that run out of sperm lay some 
unfertilized oocytes, usually at day six.  If plenty of food is present hermaphrodites may lay an 
average of 31 unfertilized eggs per worm
.
  
I found that hlh-25 animals lay more unfertilized oocytes than wild-type animals, and that 
the production of unfertilized oocytes extended much further than in wild-type animals.   As 
shown in figure 14, both wild-type and hlh-25 animals begin to lay unfertilized oocytes as early 
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as the second day of egg laying; however, hlh-25 animals lay significantly more unfertilized 
oocytes each day.   hlh-25 animals  laid an average of 133unfertilized oocytes  from egg laying 
day 2 (4 days after hatching) to egg laying day 13 (15 days after hatching), while wild-type 
animals laid an average of 27 unfertilized oocytes and stopped laying unfertilized eggs 
completely by egg laying day 8 (10 days after hatching).  
 
3.2.3 hlh-25 animals have a slower movement rate 
Because the HLH-25 expression pattern is seen in both neurons and in muscles, and 
because a number of the genes predicted to be HLH-25 targets are associated with GO term 
locomotion, I hypothesized that that HLH-25 could be required for normal body movement.  
hlh-25 animals have a normal sinusoidal movement, and their forward and reversal 
movement on solid media appears normal [95].   Although I did not assay reversal frequency, 
hlh-25 animals appear to have the same backing up phenotype as wild-type animals.  Therefore, I 
used two different assays to detect more subtle movement defects in hlh-25 animals at dauer and 
L4 stages: locomotion on solid media and thrashing in M9 solution. In the locomotion assay, I 
counted the number of body bends per minute, and in the thrashing assay, I counted each lateral 
movement over a period of one minute. The results for both assays were generally the same: hlh-
25 animals moved slower than wild type animals at both developmental stages.   Specifically, the 
hlh-25 L4 stage and dauer stage animals moved with an average of 28 and 21 fewer body bends-
per-minute than wild-type animals, respectively.  Likewise, hlh-25 animals thrashed with an 
average of 23 and 31 fewer bends per minute than wild-type animals at the L4 stage and the 
dauer stage, respectively (Figure 15-16).  
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3.2.4 HLH-25 affects organization and formation of the germline  
The hermaphroditic reproductive system consists of two, U-shaped gonad arms 
connected to a uterus and one spermatheca on each side (figure 3).  In wild type animals, oocyte 
production starts in the distal tip of the gonad arm and continues throughout the syncytial 
section, where the multinucleated mass of cytoplasm has not separated into individual cells.  In 
the syncytial section, the germline nuclei go through mitosis and meiosis while being surrounded 
by the cytoplasmic membrane. Oocytes start to compartmentalize when they reach the loop of 
the gonad, and achieve full compartmentalization as they move closer to the spermatheca.  In 
wild type animals, fully cellularized (i.e. separated into distinct cells) oocytes have the 
appearance of squared compartments with a narrow gap.   
A number of the HLH-25 target genes are known to affect either mitotic or meiotic cell 
division, including ran-1, mex-5, mex-6, and pos-1.   Often animals with mutations in these genes 
show germline abnormalities that include abnormally shaped or endomitotic oocytes.   I 
examined the gonad arms of young adult hermaphrodites and found that in approximately 75% 
of hlh-25 animal; at least one gonad arm contained irregularly shaped oocytes.  After 
compartmentalization, the oocytes were more round or tear-drop in shape, and were not tightly 
packed (Figure 17).  
 
3.2.5 HLH-25 has a role in Early Embryonic Cell Division 
The C. elegans lineage in early embryonic development begins with P0 which divides in 
AB and P1.   AB further divides into Aba and ABp; P1 further divides into EMS and P2.  These 
first divisions during embryogenesis require the presence of some of the HLH-25 targets like 
ran-1, mex-5, mex-6, and pos-1.  However, hlh-25 is not expressed until ABp and EMS 
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granddaughters in response to the Notch signaling [45].  Since C. elegans germline cells have the 
ability to silence transgene arrays [96], I wondered if HLH-25 is needed for early cell divisions 
even though I did not observe expression at early stages.   
To determine whether HLH-25 is required for early cell division, I compared the first five 
embryonic cleavages from wild type and hlh-25 animals using α-tubulin::GFP. Images were 
taken every three minutes to create a time lapse video. In vivo time-lapse imaging of seven 
different embryos reveals that hlh-25 animals have similar first embryonic cleavages to wild 
types (Figure 18).  
 
3.3 HLH-25 transcriptional network 
I used two different approaches to validate the HLH-25 transcriptional network:  reverse 
transcriptase quantitative polymerase chain reaction (RT-qPCR) and transcriptional reporters. 
RT-qPCR allows quantification of mRNA levels in whole animals. Transcriptional reporters 
allow temporal and spatial measurement of the promoter activity in live animals. 
 
3.3.1 Confirmation of HLH-25 target genes by RT-qPCR 
Our previous microarray analysis shows that HLH-25 regulates 634 genes of which 510 
were up-regulated and 124 were down-regulated.  Two of the GO term annotations assigned to 
these genes were “embryonic development ending in birth or egg hatching” and “post-embryonic 
development”.  These results suggest that HLH-25 plays an important role in embryonic and 
nematode larval development. 
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The microarray analysis was done using young adult worms, which may have contained 
developing embryos in their uterus.  Since the microarray analysis included genes necessary for 
embryonic and larval development, I wondered if HLH-25 regulated genes in both embryos and 
in larval/adult animals.  To address this, I monitored the change in RNA levels in embryos and 
L4 stage larvae.  The L4 stage was used to validate the microarray results, while the other stages 
were selected to correlate with the hlh-25 gene expression profile.  For some genes, I also 
measured expression in dauer larvae. I selected 12 genes to validate, and for all 10 of them, in 
the L4 stage expression, they were up-regulated or down-regulated to the same extend as 
indicated by the microarray analysis (Figure 19, table 2).  As described below, the selected genes 
are important during embryogenesis and at other stages in the life cycle. 
The gene ran-1 encodes the C. elegans Ran GTPase ortholog [97] which, among other 
proteins, comprises the Ran GTPase system. The GTPase cycle is known to regulate transport of 
proteins across the nuclear envelope [98, 99], chromosome positioning and nuclear envelope 
assembly [100].  Previous studies have shown that during embryogenesis ran-1 knock-out causes 
improper mitotic spindle formation, irregular chromatin structures, and fission of the pronucleus 
during meiosis [97].  This gene was up-regulated in L4-stage animals, but was down-regulated in 
embryos.  
Genes mex-5, mex-6, and pos-1 encode two CCH-finger proteins that are important for 
the establishment of embryonic polarity [101].  These three genes are maternally transcribed. 
MEX-5 and MEX-6 establish soma/germline asymmetry in the early embryo.  POS-1 is needed 
for fate specification of germ cells, pharynx, and intestine during embryogenesis [102].  These 
three proteins are needed for the first two cell divisions to occur properly [103]. Mutation to any 
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of these genes results in embryonic lethality [77, 103-108].  These three genes were up-regulated 
in L4 stage animals and down-regulated during the embryonic stage. 
The genes spn-4, cpg-2, emb-9, fat-2, sca-1, lin-37, lin-54 are necessary for 
embryogenesis.  Mutations to all of these genes results in embryonic lethality. EMB-9 is 
essential for embryonic morphogenesis, gonad elongation, and for larval development; [109].   
These genes were up-regulated at the L4 stage. spn-4, cpg-2, emb-9, fat-2, sca-1 were down-
regulated during the embryo stage. 
The genes acs-2, mtl-1, and daf-18 are necessary for homeostasis and stress adaptation 
[64, 110, 111].  Mutations to either acs-2 or mtl-1 results in reduced brood size [112, 113].  acs-2 
and mtl-1, were down-regulated in the microarray, but up-regulated  in my RT-qPCR results at 
the L4 stage.  daf-18 was up-regulated at all stages tested. 
 
3.3.2 Confirmation of HLH-25 target genes by Transcriptional Reporters 
As a second step to validate hlh-25 transcriptional network, I generated transcriptional 
reporters for five randomly selected HLH-25 target genes with the goal of establishing their 
expression pattern in the presence and absence of hlh-25.  I used the green fluorescent protein 
gene fused to the promoters of these selected genes to analyze hlh-25 dependent expression in 
live animals.  The genes chosen were selected because they were strongly up-regulated or down-
regulated in hlh-25 animals, according to the gene expression microarray, and because they had 
potential roles in development.   Genes imp-2, ima-1, pqn-95, when mutated, result in embryonic 
lethality [106, 107].   In addition to acting within the insulin signaling pathway, the genes akt-2 
and daf-18 have antagonistic affects on life span [114-116]. 
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Although, I successfully cloned the transgenes Pimp-2::GFP, Pdaf-18::GFP, Pima-
1::GFP, Ppqn-95::GFP, and Pakt-2::GFP, I did not obtain stably transgenic lines. The constructs 
were linearized, blunt ended, and injected as a low copy number to prevent transgene silencing 
[83].   I learned, practiced and successfully injected the constructs into the animals.  As a result, I 
obtained F1 progeny that carried the injection marker and displayed the “roller” phenotype; 
however the injection marker was never transmitted to F2 progeny.  Therefore, I obtained strains 
containing akt2::GFP and daf-18::GFP (fsEx84) through other sources.  Transgenic lines 
carrying akt2::GFP and daf-18::GFP (fsEx84) were kindly provided Dr. Gary Ruvkun from 
Harvard Medical School and Dr. Solari Florence from Claude Bernard University Lyon. 
 To analyze hlh-25 dependent expression of akt-2 and daf-18, I mated hlh-25 males with 
hermaphrodites carrying these constructs.  Homozygous deletion of hlh-25 was verified by PCR.  
I compared the transgene expression in these newly made strains in expression to transgenic 
wild-type animals at larval and adult stages. 
 
3.3.2.1 Validation of akt-2 as a target of HLH-25akt-2::GFP 
As shown in figure 20, akt-2::GFP is expressed in wild-type animals in head and tail 
neurons, the ventral nerve cord, muscles, spermatheca, and in the head posterior bulb.  I did not 
detect expression in the embryos of adult hermaphrodites. In hlh-25 animals, the spatial akt-
2::GFP expression was indistinguishable from the pattern in wild-type animals.  We were not 
able to reliably quantify the GFP levels to determine if there was a detectable difference in the 
level of expression. 
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3.3.2.2 daf-18 expression increases in the absence of HLH-25 
In wild-type animals, daf-18::GFP expression was first detected at the pretzel stage and 
continued after hatching, throughout adulthood.   The post-embryonic expression was localized 
only to the head neurons (Figure 22).  In hlh-25 animals, both the spatial distribution and the 
level of daf-18::GFP expression increased significantly, and correlated with cells or tissues that 
were found to express the Phlh-25: GFP in the head and tail neurons, muscles throughout the 
body, pharyngeal muscles, spermatheca and ventral nerve cord (Figure 21) .  
 
3.3.3 Genetic validation that daf-18 is a target of HLH-25 
The results presented thus far suggest that HLH-25 transcriptionally represses daf-18.    
Based on these data, I hypothesized that hlh-25 animals would have phenotypes that are similar 
to animals that overexpress daf-18.   Animals with loss of function alleles of daf-18 have shorter 
lifespans and are defective in dauer formation [114, 115].   Likewise, animals that overexpress 
daf-18 have longer lifespans, are more prone to form dauers, and have difficulty exiting the 
dauer stage [65, 117].   Therefore, I tested the lifespan and dauer exit phenotypes of hlh-25 
animals. 
 
 
3.3.4 HLH-25 animals have a longer life span  
I measured the mean life span of wild-type and hlh-25 animals at 20 °C.  As indicated 
in figure 23, hlh-25 animals have a median life span of 19 days, while wild-type animals have a 
life span of 16 days (table 3).  The extended lifespan of hlh-25 animals is similar to the 
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previously reported median lifespan of 17.4 days for daf-18;daf-2 animals expressing an 
extrachromosomal copy of daf-18 [117]  . 
 
3.3.5 HLH-25 is necessary for proper dauer exit timing 
When starvation-induced dauer larvae are placed into favorable growth conditions, they 
take approximately 60 minutes to commit to exit the dauer state at 25° C and about ten hours to 
molt into the L4 stage [87, 118-120].  Within 60 minutes, the first biological sign of dauer exit is 
the increase in fat accumulation or lipophilicity, and pharyngeal pumping starts after 
approximately 3 hours [121].   Between nine and twelve hours after the decision to exit dauer, 
vulva formation commences and is visible as the vulval crescent. Finally, between 12 and 24 
hours, recovering dauers begin to create oocytes and fertilization commences. 
In order to determine if dauer recovery depends on HLH-25 regulation of daf-18- 
expression, I compared the dauer recovery phenotypes of wild type animals with: daf-18 
mutants, animals over-expressing daf-18 (daf-18
GOF
) or hlh-25 animals.   Because deletion of 
hlh-25 increases daf-18 expression, I expected hlh-25 animals and daf-18
GOF
 animals to recover 
similarly.  
Because the time that it takes for dauer to recover varies and depends on their age and the 
environmental factor that caused them to become dauers [87, 118-120],  I induced dauer 
formation under the same conditions for all strains simultaneously, and used three day old dauers 
for the assays. 
In my dauer recovery assay, wild-type animals took an average of 12 hours (80%) to 
reach L4.  As expected, dauer recovery was similar in daf-18 animals but was longer in daf-
18
GOF
 animals.  At 12 hours, 65% of the daf-18 mutants, but only 10% of the daf-18
GOF
 animals, 
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had reached L4.  Interestingly, the dauer recovery timing of the hlh-25 mutant animals was very 
similar to the daf-18
GOF
.  After 12 hours of recovery only 35% of the hlh-25 mutant animals 
reached L4. To rescue the wild type phenotype, I reintroduced hlh-25 into hlh-25 animals (hlh-
25R).  Animals carrying hlh-25 as an extrachromosomal array were able to recover similarly to 
the wild type animals.  They took an average of 12 hours to reach L4 (Figure 24, 26).  
 
3.3.6 DAF-18 does not affect movement 
Although a role for daf-18 in locomotion and movement has not been previously 
described, I wondered if the locomotion defect of hlh-25 animals is dependent on daf-18.  
Therefore, I compared the locomotion and thrashing of daf-18 mutants to wild-type animals as 
described above in section 3.2.3.  Our results showed that daf-18 animals move at a similar rate 
as wild-type animals, and thrash slightly, but not significantly, more than wild-type with an 
average of fifteen more lateral movements than wild type  per minute (Figure 25). 
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B 
Figure 7  Embryonic Expression of Phlh-25::GFP. 
The embryo developmental stage is named on the left.  The entry zone is marked with 
an arrow. The plane of the embryo is marked as A: anterior, P: posterior, D: dorsal, V: 
ventral  
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Figure 8 Embryonic Expression of Phlh-25::GFP. 
This figure represents stills from a time lapse video of Phlh-25::GFP 
expression during progression from bean to comma  stage while still in the 
uterus. 
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  Figure 9 Larvae  Expression of Phlh-25::GFP.. 
Expression of Phlh-25::GFP  is seen (A)in tail neuron, (B-D) head muscles and (D) body muscles 
Larvae stages are specified at the right bottom of each image. Bar marks 20 µm.  
 
D 
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Figure 10 Adult  Expression of Phlh-25::GFP. 
HLH-25 expression observed in unidentified head neurons and embryos inside the adult 
hermaphrodite. Bar marks 25 µm.  
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Figure 11 Phlh-25::GFP expression in dauer. 
Expression is seen in the VNC and DNC. This image contains two focal plains of GFP 
expression in the same animal. (B) and F show the dorsal nerve cord; (C and G) show the 
ventral nerve cord. Arrows indicate the synaptic branches between VNC and the dorsal nerve 
cord. 
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Figure 12  Phlh-25::GFP  expression in the dauer head. 
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Figure 13  HLH-25 affects embryogenesis. 
(A) hlh-25 mutants have a 64% embryonic lethality versus a 14% embryo lethality in wild type 
embryos (P-value = 6.32E-14). (B) Deletion of hlh-25 also resulted in a reduced quantity of eggs laid. 
hlh-25 animals laid a total average of 208 eggs, while wild-type animals laid an average of  249 (P-
value = 0.0565). Error bars represent SEM.  
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Figure 14 Unfertilized Egg Laying Behavior of hlh-25 compared to wild-type. 
Day “1” was assigned for when the egg-laying period started. hlh-25 animals  laid an average of  133 
unfertilized oocytes while wild-type animals lay laid an average of 27 unfertilized oocytes. Error bars 
represent SEM 
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  Locomotion Thrashing 
Strain mean stdev P-value mean stdev P-value 
wild-type 71 5.77 - 104 6.55 - 
hlh-25 50 3.90 
 
<.0001 72 8.85 <.0001 
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Figure 15 Dauer Mobility Assay 
 Error bars represent SEM. (C) The band near the middle of the box represents the median. 
Outliers are indicated with an asterisk.  
 
A B 
C 
40 
  
 
 
  
 
Locomotion Thrashing 
Strain n mean stdev mean stdev 
wild-type 90 70 8.5 110 5.4 
hlh-25 90 42 13.8 88 11.7 
hlh-25R 90 44 24.2 90 14.0 
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Figure 16  L4 Locomotion and Thrashing  
Error bars represent SEM . (C-D)The band near the middle of the box represents the median. 
Outliers are indicated with an asterisk. 
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Figure 17 hlh-25 depletion causes irregular shape of oocytes 
HLH-25 affects organization and formation of the germline. hlh-25 animals contained fewere 
and irregularly shaped oocytes. The oocyte adjacent to the spermatheca is numbered-1 and 
the one farther away are -2, -3. Scale Bar:100µm 
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Figure 18 Early Embryonic Cell Division Time-lapse video.  
In vivo time-lapse still image of α-tubulin::GFP  (which expresses spindle formation) in wild-
type and hlh-25 embryos. 
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Figure 19 HLH-25 targets expression during L4 stage. 
Graph represents relative gene expression levels. Transcript levels were quantified by RT-
qPCR. Data are expressed as log2 of fold change.  
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Table 2 RTqPCR  Log 2 Comparison of hlh-25 with wild-type 
  Log2 
gene embryo L4 dauers 
mex-5 -0.140859213 0.574520826 - 
mex-6 -0.731609333 0.079969371 - 
mtl-1 -1.438593174 0.56487424 - 
spn-4 -0.755692286 0.947934039 - 
lin-54 - 0.425533103 - 
lin-37 - 1.48913987 - 
ran-1 -0.284879656 0.989225894 -0.558373223 
cpg-2 -1.768954799 2.277367657 -1.591294232 
pos-1 -0.772183582 1.017858268 0.070098511 
emb-9  -0.355788189 0.336756657 0.143902443 
fat-2 -0.087547834 1.718457624 -1.883574631 
sca-1 -0.244550149 1.270412924 -0.167984707 
acs-2 -2.427682984 1.107159331 -1.373822577 
daf-18 1.389777859 1.181618478 0.081026597 
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Figure 20 akt-2::GFP expression. 
akt-2::GFP is expressed in wild-type animals in (A-C) the head and (D-F) the tail 
neurons, the (G-I ) the ventral nerve cord, muscles, spermatheca, and in the (A-C) 
the head posterior bulb.  In hlh-25 animals, the spatial akt-2::GFP expression was 
indistinguishable from the pattern in wild-type animals (pictures not shown).  
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Figure 21 daf-18 expression changes 
In wild-type animals, daf-18::GFP expression was first detected at (A-C) the pretzel 
stage, but in a larvae, the expression was only seen in the head (figure 22 a-c). In the 
absence of HLH-25, not only the expression in embryos increased significantly (D-F), 
but also expression in the the head and tail neuron, muscles throughout the body, 
pharyngeal muscles, spermatheca and ventral nerve cord (G-I).  
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Figure 22 daf-18 head expression changes 
Expression was localized only to the head neurons (A-C), but 
in the absence of HLH-25, the expression increased in the 
head, (D-F). 
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Table 3 Life Span Measurements 
Strain 
  Total # of Animals Median Life Span 
P-value Log-
Rank 
Biological  to Die/or  of All Animals Test compared 
Replicate to be Censored (days) to N2 animals 
wild-type 1 88/13 15   
 
2 90/10 17 
   3 86/12 15   
 
all 264/35 16 
 
     hlh-25 1 93/7 20 < 0.0001 
 
2 93/7 19 0.0046 
  3 96/4 19 < 0.0001 
  all 282/18 19 < 0.0001 
Figure 23 Life span curve of wild-type versus hlh-25. 
Measurement and comparison of life span between the wild type and hlh-25 on solid NGM 
(nematode growth medium) with OP50 E. coli. 
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Table 4 Dauer Recovery 
 
 
wild-
type 
hlh-25 hlh-25R daf18- daf-18
GOF
 
hlh-25 vs 
daf-18
GOF
 
pumping 
median 3 12 3 3 6 12 
p-value 
 
< 0.0001 0.1174 0.3586 < 0.0001 0.0004 
crescent 
median 12 24 12 12 24 24 
p-value 
 
< 0.0001 0.1745 0.9619 < 0.0001 0.0386 
  
Figure 24 Dauer Recovery. 
 Visibility of A) pharyngeal pumping and B) crescent formation during 
dauer recovery was observed and recorded for twenty-four hours. 0 hrs 
marks the time dauers were placed under favorable conditions. 
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Table 5 Mobility Assay   L4 stage   
    Locomotion Thrashing   
Strain n mean stdev P-value mean stdev P-value 
Wild-type 90 70 8.5   110 5.4   
hlh-25 90 42 13.8 <.0001 88 11.7 <.0001  
daf-18- 90 71 18.1  <.0001  125 13.8  <.0001  
hlh-25R 90 44 24.2  <.0001  90 14  <.0001  
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Figure 25 Locomotion Assay 
Error bars represent SEM . (C , D) The band near the middle of the box represents the 
median. Outliers are indicated with an asterisk. 
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Figure 26 Characteristics of Dauer Recovery 
 Representative pictures of dauer recovery characteristics on NGM plates. (A) at “0” hour 
dauers are long, thin and transparent. The first sign of recovery is (B) fat acuumulation in 
the intestines and pharyngeal pumping  [1]  followed  by  (C , D) the crescent formation. 
Once the dauers reach the adult stage (F) embryos are made and laid.  
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4 DISCUSSION 
 
4.1 HLH-25 Functions During Embryogenesis 
The experiments in this research lay a foundation for understanding the role of HLH-25 in 
C. elegans during embryonic and larval development. The key challenge in this genetic research 
was to understand how the HLH-25 transcription factor affects the performances of its target 
genes by examining phenotypes caused by hlh-25 mutations. HLH-25 is actively expressed in 
embryos, larvae and adults. In the absence of hlh-25, animals show a 54% embryonic lethality, a 
reduced brood size, an increased number of unfertilized eggs, a slower movement rate, a longer 
life span, and a longer dauer recovery. The results presented offer excellent starting points to 
further characterize HLH-25, and  raised some questions that can be further examined. 
4.1.1 Is hlh-25 a maternal effect gene? 
Maternal effects genes play important roles in the early processes of embryonic 
development of different organisms, such as sea urchins, nematodes, fruit flies, zebrafish, frogs 
and mice.  Maternally synthesized proteins or mRNAs are placed in the oocytes and sometime 
after fertilization, those mRNAs are expressed in the developing embryo, or zygote.  This event 
is known as the maternal to zygotic transition (MZT) [122].   During this period, maternal 
transcripts are eliminated and the zygotic genome becomes transcriptionally activate [123].  The 
timing of MZTs differs from cell to cell, which reflects the development of distinct cell types and 
causes the maternal transcripts  to overlap with some of the early zygotic transcripts [123].   
During Drosophila embryogenesis, maternal mRNAs, such as  hunchback, bicoid, and 
nanos are required for early patterning of the embryo [9, 124-126].  Firstly, maternal hunchback 
is distributed evenly throughout the egg.  Maternal nanos mRNAs and bicoid mRNAs are 
53 
localized to the posterior and anterior pole of the mature oocyte, respectively [127].  The nanos 
protein inactivates hunchback, preventing its translation in the posterior.  Bicoid activates 
transcription of the hunchback gene which creates a concentration gradient of the hunchback 
expression along the embryo.  Hunchback activates or represses several genes depending on its 
concentration.  For instance, hunchback activates and represses kruppel [127, 128] .  Kruppel is 
necessary for differentiation, growth, and development of the embryo.  At high concentrations, 
hunchback represses kruppel, and at lower concentrations hunchback activates kruppel [128].   
The maternal effect hunchback, along with other maternal effect genes, initiates the 
embryo pattern.  Zygotic hunchback transcription creates a gradient of the hunchback protein 
which regulates genes necessary for embryo development [122]. Hunchback is necessary for 
proper morphology [122, 129-132]. Drosophila with hunchback mutations lack mouthparts and 
thorax structures [122, 129-132]. 
Different methods have been utilized to identify maternal genes in Drosophila, one of 
which is to isolate pole cells, progenitors of the germ-line stem cells, from blastodermal embryos 
by fluorescence-activated cell sorting (FACS) and then use these isolated cells in a microarray 
analysis [133, 134].  Another method is to use flow cytometry to sort GFP-labeled pole cells then 
use multidimensional protein identification technology (MuDPIT) [134-137] to identify proteins 
in both the GFP-positive and GFP-negative cells. Moreover, another method is to observe  
mRNA molecule localization by using  fluorescent labeled probes [138]. 
In C. elegans, oocytes are loaded with a number of maternally synthesized proteins and 
mRNAs that are necessary for directing the first mitotic divisions.   These include mex-5, mex-6, 
and pos-1 mRNA, all of which are required to establish the overall polarity of the embryo, and 
ran-1 mRNA, which is necessary for the first embryonic division.  Mutation of ran-1 disrupts 
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formation of the mitotic spindle and causes aberrant chromatin localization [97].  This raises the 
question about whether hlh-25 is also a maternal effect gene.  
Three observations from our experiments lead us to suggest that HLH-25 is not a 
maternal effect gene.  First, movies show that the early embryonic divisions of hlh-25 animals 
appear normal.  Second, hlh-25 is expressed in early embryos in response to Notch signaling in 
the Abp granddaughters (beginning after the eight-cell stage) and in four of the EMS 
granddaughters (MSaa, MSap, MSpa,Mspp).  The maternal-to-zygotic transition (MZT) begins 
after the second cleavage (4 Cells) [123, 139], so HLH-25 is likely just becoming active after the 
Notch-dependent induction of transcription.  Third, hlh-25 expression has not been detected in 
the somatic gonad, the intestine, or the germline of adult animals, though it is possible that our 
transgene does not reflect the full expression pattern of the gene.  In future studies to test more 
directly whether hlh-25 is or not a maternal effect gene, methods described above should be 
used. 
 
4.2 Why is the morphology of  oocytes irregular in hlh-25 animals? Why do hlh-25 animals 
have a high embryonic lethality, increased quantity of unfertilized eggs and reduced 
brood size? 
We have established that different HLH-25 target genes play different roles during 
embryogenesis.  Some of these genes, such as cpg-2 and H02I12.5, are necessary during oocyte 
formation [139], while others  are necessary after fertilization, such as ran-1. When these 
important genes are mutated or down-regulated (as they are in hlh-25 animals), embryos 
encounter different problems such as irregular oocyte formation and/or embryonic lethality.  This 
may explain why hlh-25 animals have irregular shaped oocytes, high embryonic lethality, an 
increased in unfertilized oocytes and reduced brood size.  
55 
hlh-25 embryos that die do so prior to the  tadpole stage; however, it is unknown exactly 
at what cell stage embryos stop dividing and die.  Using Hoechst dye blue fluorescent stain 
(DAPI) to stain DNA in the nucleus of the embryos could be a method for future studies to 
confirm at which cell stage embryos arrest.  Also, since overexpression of PTEN/daf-18 causes 
apoptosis of cells [140], future studies should use the TUNEL (Terminal deoxynucleotidyl 
transferase  dUTP nick end labeling) assay to detect DNA fragmentation from apoptotic cells in 
hlh-25 unhatched embryos. Furthermore, strains co-expressing fluorescent markers that target the 
plasma membrane (GFP fusion that binds PI4, 5P2) and the chromosomes (mCherry-histone 
H2B) to observe plasma membrane and chromosome, respectively, should be used as a method to 
further study the gonad architecture in hlh-25 animals. 
 
4.3 HLH-25 Function in Movement 
4.3.1 Are hlh-25 animals UNC variants? 
C. elegans move in a wave-like motion that is described as sinusoidal movement [141].  
This movement pattern is determined by antagonist movement of the ventral and dorsal body 
muscles, and it is controlled by distinct classes of motorneurons [142].  Some of these neurons 
form neuromuscular junctions with the ventral and dorsal body muscles, one of which is the 
ventral nerve cord (VNC) [142].  The expression of hlh-25 in the ventral nerve cord led us to 
examine hlh-25 animals for locomotion defects. 
Even though hlh-25 animals appear to have a sinusoidal movement, they move at a 
slower rate than wild-types.  However, this phenotype could not be rescued. The failure to rescue 
the phenotype by re-introducing the transgene suggests that HLH-25 does not function in 
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locomotion.  There are two other alternative possibilities.  First, the hlh-25 deletion was created 
using EMS (Ethyl methanesulfonate), which produces random mutations in the genetic material. 
Although, hlh-25 animals were extensively outcrossed in order to reduce genetic abnormalities, 
there could be a mutation in a gene located close to hlh-25 and on the same chromosome that is 
necessary for movement. Second,  it is possible that the transgene is not expressed at high 
enough levels in the cells to rescue movement.  Future studies can address these possibilities, by 
testing additional transgenic lines, which may express hlh-25 in different cells,  for the ability to 
rescue the movement phenotype. 
 
4.4 Stage Dependent Regulation by HLH-25 
4.4.1 Does HLH-25 act as both, a transcriptional activator and a transcriptional repressor? 
Generally, transcription factors are characterized by their mechanism of transcriptional 
regulation.  Transcription factors typically act to either repress or activate transcription: many 
may activate one group of genes while and to repress a different group of genes [143, 144] .  
Importantly, only a few transcription factors are known to act both as an activator and as a 
repressor of the same gene.  For instance, Mcml, a yeast transcription factor, affects both 
activation and repression of α-specific genes [145]  in yeast mating-type switching.  In 
Arabidopsis, the homeodomain-leucine zipper ATHB2 and the basic helix–loop–helix (bHLH) 
PIL1 transcription factor, activate genes implicated in the elongation response provoked by 
neighbor shade, and repress the same genes when neighbor shade  is no longer detected [146, 
147].   
Our results show that in C. elegans a number of the genes that are activated by HLH-25 
during embryogenesis are repressed by HLH-25 in during L4 stage.  In order to attempt to 
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explain why hlh-25 activates and represses some of its target genes but only represses  daf-18, I 
looked for the hlh-25 binding sites within 2000 base pairs upstream of the ATG start codon of 
the target genes previously validated by RTqPCR.  As explained in section 1.3, HLH-25 
recognizes five different consensus sequences.  Genes cpg-2 and ima-1, have three of the five 
HLH-25 consensus sequence binding site [55].  Genes ran-1, pos-1, imp-2, pqn-95, acs-2 and 
daf-18 only have one of the five HLH-25 consensus sequence binding sites (Table 5) [55].  Even 
though HLH-25 both activates and represses acs-2 and only represses daf-18, these genes  share 
the same HLH-25 consensus sequence binding site, “CACACG”.   This result raises the question 
of whether HLH-25 regulates gene expression in a stage-dependent manner. To examine this, 
future studies should prepare microarrays comparing wild-types with hlh-25 mutants at all 
stages.      
 Table 5 Location of the HLH-25 binding sites 
Gene 
Consensus 
Sequence 
Location 
Upstream of the 
ATG 
Gene 
Consensus 
Sequence 
Location 
Upstream of the 
ATG 
cpg-2 
CATACG -129 daf-18 CACACG -468 
CACACG -608 
lin-34 
CATGCG -1694 
CATGCG -1614 CACGCT -1533 
ima-1 
CACGCG -264 mtl-1 CACACG -398 
CATGCG -311 pqn-95 CATGCG -537 
CATACG -991 imp-2 CATACG -1512 
pos-1 CACGCT -636 mex-5 none - 
ran-1 CACGCT -1948 mex-6 none - 
sca-1 none - spn-4 CACGCT -415 
emb-9 none - acs-2 CACACG -281 
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4.5 HLH-25 links Notch signaling to the PTEN pathway. 
  
DAF-18, in C. elegans, is the ortholog of the human tumor suppressor PTEN (phosphatase 
and tensin homolog), and HLH-25 is an ortholog of Hairy/Enhancer of Split (HES).  Both of 
them are important for development.  PTEN, helps regulate the cell cycle and cell division 
through the  PI3-kinase pathway [26, 148, 149] by dephosphorylating PIP3 
(phosphatidylinositol-3,4,5-trisphosphate) [150].  Either PTEN gain of function or loss of 
function causes irregularities in development.   For instance, mutations to PTEN have been 
associated with the autosomal-dominant disorder Cowdens-Disease and with different types of 
cancer such as prostate cancer and malignant glioma.  Overexpression of PTEN induces 
apoptosis and cell cycle arrest. For instance, overexpression of PTEN in MCF-7 breast cancer 
cells, causes G1 cell arrest and cell death [140].  Furthermore, HES proteins are important 
regulators of a variety of genes that influence cell proliferation and differentiation in embryo 
development [38].  HES mutations have been associated with lung and breast cancer in mammals 
[43, 44]  and with oocyte death [29]. 
HES and HLH-25 are direct targets of Notch signaling [34-36, 45].  Our findings show that 
daf-18 expression is regulated by HLH-25, providing a link between Notch signaling and PTEN 
mediated control of cell proliferation.  Future studies in the lab can further exploit the 
relationship between HLH-25 and daf-18 by analyzing the expression of daf-18::GFP in animals 
lacking the Notch signaling, LIN-12/Notch. 
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Figure 27 Role comparisons between humans and C. elegans. 
This diagram is based on previous experiments and the one presented here. In humans, HES 
is activated by Notch signaling. HES represses PTEN. PTEN prevents AKT complex 
phosphorylation allowing mTOR to enter the nucleus to control cell cycle. Similarly, in C. 
elegans, HLH-25 is activated by Notch signaling. HLH-25 represses daf-18/PTEN. daf-
18/PTEN prevents AKT complex phosphorylation allowing DAF-16 to enter the nucleus.  
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 Table 7 RTqPCR Probes 
Gene Probe Gene Probe Gene Probe 
cpg-2 Ce02448570_gl acs-2 Ce024861991_gl lin-37 Ce02448521 
pos-1 Ce02478511_g1 mex-6 Ce02437281 lin-54 Ce02466796 
ran-1 Ce02452473_gl daf-18 Ce024851888_ml spn-4 Ce024716594gl 
pmp-3 Ce02485188_ml mex-5 Ce02466891 fat-2 Ce02466860_ml 
sca-1 Ce02452547_gl mtl-1 Ce0255141si   
 
  
 
